PanACEA

A drug development programme to shorten and simplify treatment of tuberculosis.

[PanACEA @PanACEA_II]

Day 3 — the final day of the SimpliciTB & PanACEA II close-out meeting.
Today we’re not just wrapping up, we’re planning forward: shaping the future of TB research, collaboration & innovation. Grateful for the journey, excited for what’s ahead. @edctp @tballiance #endTB

[PanACEA @PanACEA_II]

Kicking off Day 2 of the SimpliciTB & Panacea II close out Meeting in Cape Town! Yesterday reminded us how far we’ve come — from milestones in clinical progress to growing global partnerships. Onward together in the fight against #TB. @EDCTP @TBAlliance #PanaceaII #EndTB

[PanACEA @PanACEA_II]

The joint final annual meeting of #SimplicitTB and #PanaceaII kicks off in Cape Town! Looking forward to an inspiring 3 days of collaboration, science & progress in TB research. Let’s go! 🇿🇦 #TBResearch #GlobalHealth #CapeTown #EDCTP #endtb

[PanACEA @PanACEA_II]

Exciting news from Uganda! Our 6the partner site is now officially ready for patient enrollment in our PanACEA II STEP2C trial!! @EDCTP @MakerereHosp #EndTB

[PanACEA @PanACEA_II]

Looking back at another great edition of the EDCTP forum! We were very happy to see so many of our PanACEA members attending and contributing to the insightful sessions. And we were proud to see some of the amazing PanACEA work presented! @EDCTP @KCRITanzania @TBtrials_StAnd

[PanACEA @PanACEA_II]

We are happy to announce that after the SIV our site in Malawi is now ready to start with the STEP2C study! @EDCTP @MakerereHosp @Makerere #EndTB

[PanACEA @PanACEA_II]

Great presentation from our partner dr. Caryn Upton at the EDCTP forum in Paris @taskapplied @EDCTP @TBtrials_StAnd

[TB Trials @ Uni of St Andrews @TBtrials_StAnd]

Delighted to meet our partners at #EDCTPForum learning about the new @EDCTP programme and opportunities for collaboration #EndTB @SabiitiwWilber @Infection_StAnd @UStAResearch @StAndMedicine @TBAlliance @PanACEA_II

[PanACEA @PanACEA_II]

A good idea: Staggered dosing of rifampicin using to minimise tolerability problems and maximize efficacy https://t.co/kkYEAU1c7B

[PanACEA @PanACEA_II]

We successfully completed our first site initiation visit for the STEP2C study at TASK in South Africa. We are so excited to start enrolling our first patient soon! @PanACEA_II @EDCTP

[PanACEA @PanACEA_II]

Today Norbert Heinrich presented the PanACEA SUDOCU study results at @CROI_Official in Seattle: sutezolid on top of a background regimen (bedaquiline, delamanid, moxifloxacin) was well tolerated when given over 12 weeks and improved the treatment efficacy modestly. TNX to @EDCTP

[PanACEA @PanACEA_II]

After two years of COVID we are finally reunited with our PanACEA family in #Malawi. With special thanks to our host @KUHeS_mw. @EDCTP @TBtrials_StAnd

[TB Trials @ Uni of St Andrews @TBtrials_StAnd]

A busy first day at our Annual Scientific Meeting is followed by a fantastic dinner at Ekhaya Lodge #Mangochi
SimpliciTB @PanACEA_II @EDCTP @TBAlliance @StAndMedicine @Infection_StAnd

[NIMR Mbeya @NIMRMbeya]

Our Centre Director @NNtinginya presenting on the clinical utility of the Molecular Bacterial Load Assay (MBLA) in monitoring TB therapy through the @EDCTP funded SimpliciTB-PanACEA network at Kamuzu University of Health Sciences, Malawi @KUHeS_mw @PanACEA_II

[TB Trials @ Uni of St Andrews @TBtrials_StAnd]

Our SimpliciTB @PanACEA_II TB-MBLA workshop is starting its second day in @KUHeS_mw #Blantyre #Malawi @StAndMedicine @Infection_StAnd @univofstandrews @EDCTP @TBAlliance @NIMRMbeya
#Training #Development #Tuberculosis

[TB Trials @ Uni of St Andrews @TBtrials_StAnd]

Looking forward to welcoming our SimpliciTB delegates arriving @MakokolaRetreat #Malawi ready for our Annual Scientific Meeting with @PanACEA_II @EDCTP @TBAlliance @StAndMedicine @Infection_StAnd
#Takulandilani

[PanACEA @PanACEA_II]

Status update: DECODE recruitment finalized! This is the second dose finding study PanACEA completed in 2022. We continue to work together with LegoChemBio to get those long anticipated delpazolid exposure-response results.

https://t.co/5YIcHfb1EU

[PanACEA @PanACEA_II]

https://t.co/W4Qzy8Dbsn
“STATUS update: SUDOCU completed recruitment! Now all efforts towards wrapping up participant follow-up and data collection.
Hopefully soon more sutezolid exposure-response results...”

[PanACEA @PanACEA_II]

Today UNITE4TB is officially announced, huge project coordinated from @radboudumc that will accelerate TB regimen development. Many @PanACEA_II representatives participating, congratulations!

https://t.co/6UC16rvfQd

[Wilber Sabiiti @SabiitiwWilber]

Getting tools for TB treatment monitoring out to the world #TBMBLA @vitalbacteria @Infection_StAnd @StAndMedicine @TBtrials_StAnd @univofstandrews @WillySsengooba @StopTB @derekjsloan @GCRF @MpagamaStellah @NIMRMbeya @NNtinginya @MakerereU @KCRITanzania @PanACEA_II @EDCTP